Načítá se...
SU116. Longitudinal Epigenetic Analysis of Clozapine Use in Treatment-Resistant Schizophrenia
Background: Approximately one-third of patients with schizophrenia are considered treatment resistant. For these patients, the atypical antipsychotic drug clozapine is recommended as the only evidence-based treatment available. However, there is still significant variability in treatment response an...
Uloženo v:
| Vydáno v: | Schizophr Bull |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5476147/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbx024.112 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|